MicroAire Surgical Instruments — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

MicroAire Surgical Instruments is a long-established, privately-held player in the medical device sector, focusing on powered instruments for orthopedic and plastic surgery. Its core technology platforms include the Power-Assisted Liposuction (PAL) system and the SmartRelease endoscopic carpal tunnel release (ECTR) device, both of which are commercialized and claim significant market adoption. The company operates a manufacturing and B2B sales model, generating revenue through the sale of its instruments, handpieces, and consumables to hospitals and surgeons worldwide. Its strategy centers on iterative product upgrades and leveraging a global distribution network.

OrthopedicsPlastic Surgery

Technology Platform

Design and manufacturing of powered, handheld surgical instruments for tissue manipulation and release, including reciprocating cannula systems for liposuction and endoscopic devices for carpal tunnel release.

Opportunities

Growth is driven by the global rollout of next-generation systems like PAL SYNERGY, the recurring revenue model from high-margin consumables and single-use kits, and expansion into emerging markets with growing demand for elective surgical procedures.

Distributing complementary products like the hapo Exoskeleton can broaden the portfolio.

Risk Factors

Key risks include intense competition from alternative body contouring and minimally invasive surgical technologies, potential slowdowns in elective plastic surgery due to economic downturns, and ongoing regulatory hurdles for new devices and market expansions.

Competitive Landscape

MicroAire competes in the liposuction device market against companies offering laser, ultrasound, and water-assisted technologies. In carpal tunnel release, it competes with other medical device firms producing endoscopic and open release instruments. Its competitive edge is based on surgeon loyalty, proven clinical data on efficiency, and a comprehensive ecosystem of devices and consumables.

More companies in Diagnostics & Precision Medicine →More companies in United States →